Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity

Report ID : 40506 | PUID:- PMG02 | Published : Aug-2022 | Pages: 117 | Format: /

Pdf
Excel
Word
Ppt

Asia Pacific pharmacovigilance and drug safety software market will grow by 8.9% annually with a total addressable market cap of $817.5 million over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 30 tables and 59 figures, this 117-page report “Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Country. Based on Functionality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Adverse Event Reporting Software • Drug Safety Audits Software • Issue Tracking Software • Fully Integrated Software Based on Clinical Phase, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pre-clinical • Phase I • Phase II • Phase III • Phase IV By Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Spontaneous Reporting • Intensified ADR Reporting • Targeted Spontaneous Reporting • Cohort Event Monitoring • EHR Mining By Delivery Mode, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • On-premise Delivery • On-demand Delivery By Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Respiratory Disorders • Cardiology • Neurology • Immunology • Pain Management • Other Indications By End Users, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical and Biotechnology Companies • Contract Research Organizations (CROs) • Business Process Outsourcing Firms (BPOs) • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Functionality, Delivery Mode and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Ab Cube Accenture PLC ArisAsia Pacific LLC Cognizant Technology Solutions Corporation Ennov Solutions Inc. Extedo GmbH Honeywell International Inc. (Sparta Systems Inc.) IQVIA Inc. Max Application Oracle Corporation Sarjen Systems Pvt. Ltd. United BioSource LLC Veeva Systems Inc. Wipro Limited (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 14 1.2.6 Market Size/Share Estimation 15 1.2.7 Research Limitations 16 1.3 Executive Summary 17 2 Market Overview and Dynamics 20 2.1 Market Size and Forecast 20 2.1.1 Impact of COVID-19 on World Economy 21 2.1.2 Impact of COVID-19 on the Market 25 2.2 Major Growth Drivers 27 2.3 Market Restraints and Challenges 32 2.4 Emerging Opportunities and Market Trends 35 2.5 Porter’s Fiver Forces Analysis 39 3 Segmentation of Asia Pacific Market by Functionality 43 3.1 Market Overview by Functionality 43 3.2 Adverse Event Reporting Software 45 3.3 Drug Safety Audits Software 46 3.4 Issue Tracking Software 47 3.5 Fully Integrated Software 48 4 Segmentation of Asia Pacific Market by Clinical Phase 49 4.1 Market Overview by Clinical Phase 49 4.2 Pre-clinical 51 4.3 Phase I 52 4.4 Phase II 53 4.5 Phase III 54 4.6 Phase IV 55 5 Segmentation of Asia Pacific Market by Method 56 5.1 Market Overview by Method 56 5.2 Spontaneous Reporting 58 5.3 Intensified ADR Reporting 59 5.4 Targeted Spontaneous Reporting 60 5.5 Cohort Event Monitoring 61 5.6 EHR Mining 62 6 Segmentation of Asia Pacific Market by Delivery Mode 63 6.1 Market Overview by Delivery Mode 63 6.2 On-premise Delivery 65 6.3 On-demand Delivery 66 7 Segmentation of Asia Pacific Market by Indication 67 7.1 Market Overview by Indication 67 7.2 Oncology 69 7.3 Respiratory Disorders 70 7.4 Cardiology 71 7.5 Neurology 72 7.6 Immunology 73 7.7 Pain Management 74 7.8 Other Indications 75 8 Segmentation of Asia Pacific Market by End User 76 8.1 Market Overview by End User 76 8.2 Pharmaceutical and Biotechnology Companies 78 8.3 Contract Research Organizations (CROs) 79 8.4 Business Process Outsourcing Firms (BPOs) 80 8.5 Other End Users 81 9 Asia-Pacific Market 2021-2031 by Country 82 9.1 Overview of Asia-Pacific Market 82 9.2 Japan 85 9.3 China 88 9.4 Australia 90 9.5 India 92 9.6 South Korea 94 9.7 Rest of APAC Region 96 10 Competitive Landscape 98 10.1 Overview of Key Vendors 98 10.2 New Product Launch, Partnership, Investment, and M&A 101 10.3 Company Profiles 102 Ab Cube 102 Accenture PLC 104 ArisAsia Pacific LLC 105 Cognizant Technology Solutions Corporation 106 Ennov Solutions Inc. 107 Extedo GmbH 108 Honeywell International Inc. (Sparta Systems Inc.) 109 IQVIA Inc. 110 Max Application 111 Oracle Corporation 112 Sarjen Systems Pvt. Ltd. 113 United BioSource LLC 114 Veeva Systems Inc. 115 Wipro Limited 116 RELATED REPORTS 117 List of Tables: Table 1. Snapshot of Asia Pacific Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 18 Table 2. World Economic Outlook, 2021-2031 22 Table 3. World Economic Outlook, 2021-2023 23 Table 4. Main Product Trends and Market Opportunities in Asia Pacific Pharmacovigilance and Drug Safety Software Market 35 Table 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 43 Table 6. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 49 Table 7. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 56 Table 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 63 Table 9. Asia Pacific Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 67 Table 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 76 Table 11. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 83 Table 12. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 87 Table 13. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 87 Table 14. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 87 Table 15. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 89 Table 16. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 89 Table 17. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 89 Table 18. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 91 Table 19. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 91 Table 20. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 91 Table 21. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 93 Table 22. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 93 Table 23. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 93 Table 24. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 95 Table 25. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 95 Table 26. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 95 Table 27. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 97 Table 28. Ab Cube: Company Snapshot 102 Table 29. Ab Cube: Business Segmentation 103 Table 30. Ab Cube: Product Portfolio 103

n/a


Quick Contact Us

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select Licence Type
$3500
$4800
$6100
Our Clients